A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine.

Randomized controlled trial · Brain Behav Immun · 2024. Source record refreshed; an explanation has not been reviewed.

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Wang HF, Liu WC, Zailani H et al.
Brain Behav Immun · 2024

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.